RVPH icon

Reviva Pharmaceuticals
RVPH

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$2.67
661% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Chardan Capital
Chardan Capital
Keay Nakae
100% 1-yr RVPH win rate
5 Jan ‘26 11 days ago
D. Boral Capital
D. Boral Capital
Jason Kolbert
36% 1-yr RVPH win rate
23 Dec ‘25 24 days ago
HC Wainwright & Co
HC Wainwright & Co
Raghuram Selvaraju
0% 1-yr RVPH win rate
23 Dec ‘25 24 days ago